New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

11

In 12 U.S. states, at least 35% are obese, 2019 CDC data shows

Adult obesity is rising in the United States – with a greater impact on racial and ethnic minorities – a U.S. Centers for Disease Control (CDC) report showed, at a time when the health condition is seen causing heightened risk for severe Covid-19.

12

Pfizer vaccine trial bets on early win against coronavirus, documents show

Pfizer vaccine trial bets on early win against coronavirus, documents show (Reuters) – Pfizer Inc PFE.N is betting that its coronavirus vaccine candidate will show clear evidence of effectiveness early in its clinical trial, according to the company and internal documents reviewed by Reuters that describe how the trial is being run. In recent weeks, […]

15

BioNTech Bolsters Covid-19 Vaccine Manufacturing with Purchase of Novartis Facility

In anticipation of data from a Phase III vaccine candidate study potentially becoming available in October, Germany’s BioNTech acquired a manufacturing facility from Novartis to boost production capabilities for the preventative treatment for the novel coronavirus.

16

Finch Closes $90 Million Series D to Advance C. Difficile Infection Product

Somerville, Massachusetts-based Finch Therapeutics closed a $90 million Series D financing, with plans to use the funds to advance the company’s lead candidate CP101 for recurrent C. difficile infection through the final stages of clinical development and regulatory submission.

18

NIH launches trial of Rigel drug for severe Covid-19

The U.S. National Institutes of Health launched a clinical trial of fostamatinib, currently used to treat a blood platelet-destroying autoimmune disorder, in patients hospitalized with severe Covid-19.

20

Q&A with FCB Health Network’s Fernando Fernandez

Fernando Fernandez, Managing Director of FCB Health Network’s BX – Brand Experience Design Group, talked to Med Ad News about how COVID-19 has changed the way people interact with brands, how branding innovations such as audio and motion identities are making their way to pharma, and other topics.